Stanley Erck, Novavax CEO (Lee Jin-wook/Yonhap via AP Images)
July 13, 2022 10:35 AM EDT
Coronavirus

Covid-19 roundup: FDA re­port­ed­ly set to au­tho­rize No­vavax jab; As­traZeneca says its shot just as ef­fec­tive as mR­NA

Tyler Patchen

News Reporter

Though No­vavax has been go­ing down a wind­ing path to get a EUA from the FDA, the Mary­land-based biotech may soon be re­ceiv­ing some good …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times